Team
The team includes four individuals that have complimentary skills, three of which include the founding members. The founding members include Ms Blanche LeeShong the Chief Executive Officer is a dynamic leader who is a life coach with extensive financials. Dr Cornelius Ssemakalu the Chief Technology Officer of Iraka Biotech (Pty) LTD is a research leader and specialist in molecular biology and immunology, and and is the co-inventor of the inactivation vaccine platform. Mr Mark Johnson is a business development manager with extensive experience in the technology transfer of biotechnology and chemistry technologies. Mr Johnson is also a co-inventor of the inactivation vaccine platform. The company is currently in the process of appointing the fourth person, a female research technician, to undertake the necessary laboratory work.